Simply Wall St.85d agobearish
What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
InvestorsHub95d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaThe Wall Street Journal97d agobearish
U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with IranThe Wall Street Journal97d agobearish
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger TalksThe Wall Street Journal174d agobearish
Regeneron Stock Tumbles on Melanoma Drug-Trial MissThe Wall Street Journal174d agobearish
Regeneron Melanoma Drug Trial Disappoints and Shares Slide